Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Common Equity: 2021-2024

Historic Common Equity for biote (BTMD) over the last 4 years, with FY2024 value amounting to -$105.9 million.

  • biote's Common Equity rose 4418.45% to -$72.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.8 million, marking a year-over-year increase of 4418.45%. This contributed to the annual value of -$105.9 million for FY2024, which is 18984.84% down from last year.
  • As of FY2024, biote's Common Equity stood at -$105.9 million, which was down 18984.84% from -$36.5 million recorded in FY2023.
  • biote's 5-year Common Equity high stood at $4.1 million for FY2021, and its period low was -$105.9 million during FY2024.
  • Over the past 4 years, biote's median Common Equity value was -$47.4 million (recorded in 2022), while the average stood at -$49.2 million.
  • Per our database at Business Quant, biote's Common Equity tumbled by 151270.3% in 2022 and then soared by 3728.59% in 2023.
  • Annual analysis of 4 years shows biote's Common Equity stood at $4.1 million in 2021, then crashed by 1512.7% to -$58.3 million in 2022, then skyrocketed by 37.29% to -$36.5 million in 2023, then tumbled by 189.85% to -$105.9 million in 2024.
  • Its Common Equity was -$105.9 million in FY2024, compared to -$36.5 million in FY2023 and -$58.3 million in FY2022.